Encompass Health Corporation offers in-home and post-acute health care services in the United States. The company is headquartered in Birmingham, Alabama.
| Revenue (TTM) | $6.21B |
| Gross Profit (TTM) | $2.72B |
| EBITDA | $1.46B |
| Operating Margin | 18.00% |
| Return on Equity | 25.00% |
| Return on Assets | 9.80% |
| Revenue/Share (TTM) | $62.25 |
| Book Value | $26.29 |
| Price-to-Book | 4.69 |
| Price-to-Sales (TTM) | 1.97 |
| EV/Revenue | 2.405 |
| EV/EBITDA | 9.95 |
| Quarterly Earnings Growth (YoY) | 10.80% |
| Quarterly Revenue Growth (YoY) | 9.60% |
| Shares Outstanding | $98.65M |
| Float | $97.65M |
| % Insiders | 0.87% |
| % Institutions | 100.56% |
Volatility is currently expanding
The transaction realized approximately $1.1 million at a weighted average price of $125.95 per share. The executive reduced his direct common stock holdings by 11% through this open-market sale.
Coltharp executed the sale of 18,869 shares at a weighted average price of $125.38 per share on August 10. The transaction reduced the executive's direct equity position by 27%, while his total beneficial ownership decreased by 7%.
The transaction involved 173,148 shares sold at a weighted average price of $125.47, totaling approximately $21.7 million. This disposition represents 39% of the CEO's direct common stock holdings in the company.
BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of an additional $100 million in aggregate principal amount of its 5.875% senior notes due 2034 (the "Additional Notes") at a price of 98.75% of the principal amount thereof.
BIRMINGHAM, Ala., Aug. 10, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it has commenced a private offering of an additional $100 million in aggregate principal amount of 5.875% senior notes maturing in 2034 (the "Additional Notes"), subject to market and other conditions.
EHC beats Q2 earnings estimates as higher patient revenues and strong discharge growth drive results, leading the company to raise its 2026 adjusted EPS outlook.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Encompass Health Corporation (EHC) Q2 2026 Earnings Call Transcript
Increases full-year guidance Announces increase in common stock repurchase authorization BIRMINGHAM, Ala., Aug. 5, 2026 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the second quarter ended June 30, 2026.
Hospital operator Encompass Health Corporation EHC is set to report second-quarter 2026 results on Aug. 5, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter's earnings is currently pegged at $1.48 per shareon revenues of $1.57 billion.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on EHC and any ticker you trade — then tracks every position and per-strategy win rate.
